Rapid platelet-function assay - An automated and quantitative cartridge-based method

被引:207
作者
Smith, JW
Steinhubl, SR
Lincoff, AM
Coleman, JC
Lee, TT
Hillman, RS
Coller, BS
机构
[1] Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[2] Accumetr Inc, San Diego, CA USA
[3] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
关键词
platelets; glycoproteins; drugs;
D O I
10.1161/01.CIR.99.5.620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The platelet glycoprotein (GP) IIb/IIIa receptor is important in mediating platelet thrombus formation, and the GP IIb/IIIa antagonist abciximab (c7E3 Fab; ReoPro) is effective in preventing thrombotic ischemic cardiovascular complications of unstable angina and percutaneous coronary interventions. Small-molecule antagonists of GP IIb/IIIa based on the Arg-Gly-Asp (RGD) sequence show similar benefit, and some of these agents are orally active. However, there may be significant interindividual variation in response to such antagonists, especially with chronic oral therapy. It will be essential to balance the beneficial antithrombotic effect of these drugs with their potential for causing bleeding. In response to this need, we have developed a rapid platelet-function assay (RPFA), a point-of-care system that provides a quantitative measure of the competence of the GP IIb/IIIa receptor as reflected in the ability of platelets to agglutinate fibrinogen-coated beads. Methods and Results-Polystyrene beads were coated with fibrinogen and placed in a cartridge along with a lyophilized peptide that activates the thrombin receptor. Anticoagulated whole blood was added to the cartridge, and then a microprocessor-controlled operation mixed the reagents and detected agglutination between platelets and coated beads. Quantitative digital results were displayed within 3 minutes. Because there is no dilution of the blood, the assay can be used to measure platelet activity in samples that have been treated with GP IIb/IIIa antagonists with high dissociation rates. RPFA results of whole-blood samples treated with different GP IIb/IIIa antagonists correlated well with both conventional turbidimetric platelet aggregation (r(2)=0.95) and the percentage of free GP IIb/IIIa molecules in the sample (r(2)=0.96). The mean difference in measurements between RPFA and aggregometry was -4% (+-4% SD), and the mean difference in measurements between RPFA and free GP IIb/IIIa receptors was -2% (+/-6% SD). Conclusions-The RPFA provides rapid information on platelet function that mirrors turbidimetric platelet aggregation and reflects GP IIb/IIIa receptor blockade.
引用
收藏
页码:620 / 625
页数:6
相关论文
共 12 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[3]  
Cannon CP, 1998, CIRCULATION, V97, P340
[4]  
Coller BS, 1997, CIRCULATION, V95, P860
[5]  
Coller BS, 1998, CIRCULATION, V97, P4
[6]  
COLLER BS, 1993, J BIOL CHEM, V268, P20741
[7]   Differential dose-response to oral xemilofiban after antecedent intravenous abciximab - Administration for complex coronary intervention [J].
Kereiakes, DJ ;
Runyon, JP ;
Kleiman, NS ;
Higby, NA ;
Anderson, LC ;
Hantsbarger, G ;
McDonald, S ;
Anders, RJ .
CIRCULATION, 1996, 94 (05) :906-910
[8]   THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS [J].
SCATCHARD, G .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1949, 51 (04) :660-672
[9]   RANDOMIZED TRIAL OF A GPIIB/IIIA PLATELET RECEPTOR BLOCKER IN REFRACTORY UNSTABLE ANGINA [J].
SIMOONS, ML ;
DEBEER, MJ ;
VANDENBRAND, MJBM ;
VANMILTENBURG, AJM ;
HOORNTJE, JCA ;
HEYNDRICKX, GR ;
VANDERWIEKEN, LR ;
DEBONO, D ;
RUTSCH, W ;
SCHAIBLE, TF ;
WEISMAN, HF ;
KLOOTWIJK, P ;
NIJSSEN, KM ;
STIBBE, J ;
DEFEYTER, PJ .
CIRCULATION, 1994, 89 (02) :596-603
[10]  
Simpfendorfer C, 1997, CIRCULATION, V96, P76